SF
SBIO icon

Synovus Financial’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Synovus Financial’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-400
Closed -$13K – 2044
2020
Q1 		$13K Buy
+400
New +$15.3K ﹤0.01% 1504

Other funds holding SBIO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Synovus Financial's SBIO Position: Q2 2020 in Review

Synovus Financial sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2020, closing a stake of 400 shares — an estimated $13K sold.

Synovus Financial first reported a position in SBIO in Q1 2020 and held it in 1 quarter. The position peaked at $13K in Q1 2020. 53 funds tracked by Wall St. Rank hold SBIO as of Q2 2020.

  • Synovus Financial reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2020 after selling out during the quarter.
  • Synovus Financial sold 400 ALPS Medical Breakthroughs ETF shares in Q2 2020, an estimated $13K.
  • Synovus Financial first reported a position in ALPS Medical Breakthroughs ETF in Q1 2020 and held it in 1 quarter.
  • Synovus Financial's ALPS Medical Breakthroughs ETF position peaked at $13K in Q1 2020.
  • 53 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.